Stockscreener 앱 받기
73.24
2.35%
-1.76
시간 외 거래:
73.24
전일 마감가:
$75.00
열려 있는:
$73.84
하루 거래량:
1.47M
Relative Volume:
0.77
시가총액:
$37.08B
수익:
$10.03B
순이익/손실:
$1.07B
주가수익비율:
33.75
EPS:
2.17
순현금흐름:
$1.39B
1주 성능:
-5.85%
1개월 성능:
-9.32%
6개월 성능:
-21.08%
1년 성능:
-25.85%
1일 변동 폭
$73.22
$74.03
1주일 범위
$73.22
$77.94
52주 변동 폭
$73.22
$100.71
Alcon Inc Stock (ALC) Company Profile
ALC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
73.24 | 37.08B | 10.03B | 1.07B | 1.39B | 2.17 |
|
ISRG
Intuitive Surgical Inc
|
438.12 | 159.16B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
180.59 | 53.33B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
267.31 | 40.15B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
254.48 | 18.69B | 2.96B | 487.70M | 344.00M | 6.68 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-05-20 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-05-14 | 재확인 | BTIG Research | Buy |
| 2025-03-28 | 재확인 | Needham | Buy |
| 2025-03-25 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-01-24 | 재확인 | Needham | Buy |
| 2025-01-10 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | 재확인 | Needham | Buy |
| 2024-11-12 | 재확인 | Needham | Buy |
| 2024-10-10 | 업그레이드 | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-04-10 | 개시 | Goldman | Buy |
| 2024-03-14 | 개시 | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | 개시 | Bernstein | Outperform |
| 2023-12-18 | 다운그레이드 | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | 개시 | Stifel | Buy |
| 2023-12-04 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-05-30 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-05-10 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | 업그레이드 | Societe Generale | Sell → Hold |
| 2022-12-22 | 개시 | Mizuho | Buy |
| 2022-11-17 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2022-08-11 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2022-05-13 | 재개 | Credit Suisse | Outperform |
| 2022-05-12 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | 개시 | Needham | Buy |
| 2022-03-11 | 개시 | BofA Securities | Buy |
| 2022-01-18 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | 개시 | Oppenheimer | Perform |
| 2021-07-14 | 개시 | Deutsche Bank | Buy |
| 2021-05-06 | 업그레이드 | Citigroup | Sell → Neutral |
| 2021-03-22 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2020-11-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-07-06 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-07-06 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-04-08 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | 업그레이드 | Argus | Hold → Buy |
| 2020-03-24 | 업그레이드 | Societe Generale | Sell → Hold |
| 2020-03-13 | 업그레이드 | UBS | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-26 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-01-08 | 개시 | Argus | Hold |
| 2019-10-29 | 개시 | Stephens | Equal-Weight |
| 2019-08-21 | 재확인 | BofA/Merrill | Neutral |
| 2019-06-24 | 개시 | SVB Leerink | Mkt Perform |
| 2019-06-14 | 개시 | BTIG Research | Neutral |
| 2019-05-10 | 개시 | Robert W. Baird | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
모두보기
Alcon Inc 주식(ALC)의 최신 뉴스
What Makes Alcon (ALC) a Good Investment? - Yahoo
Major shareholder Yunqi Capital to vote against Staar Surgical 's proposed sale to Alcon - MSN
Alcon unveils $60M facility expansion in Cabell County - WOWK 13 News
Alcon investing $60 million in its West Virginia facility in Cabell County - WCHS
Alcon AG stock hits 52-week low at $74.83 By Investing.com - Investing.com UK
Broadwood opposes Alcon’s acquisition of STAAR Surgical - Investing.com India
Broadwood opposes Alcon’s acquisition of STAAR Surgical By Investing.com - Investing.com South Africa
STAAR SHAREHOLDER ALERT: Kaskela Law LLC Investigates Fairness of Proposed STAAR Surgical Company (NASDAQ: STAA) Shareholder Buyout and Encourages Investors to Contact the Firm to Discuss their Legal Rights and Options - GlobeNewswire Inc.
Alcon Move to Acquire STAAR Surgical for $1.5 Billion Opposed by Broadwood Partners - MarketScreener
Broadwood Partners (27.5% Owner) Opposes STAAR's $28/Share Alcon Deal | STAA Stock News - Stock Titan
Alcon considers moving manufacturing lines to Fort Worth from Europe, creating hundreds of jobs - The Business Journals
STAAR Surgical’s Shareholder Yunqi Capital Opposes Proposed Merger With Alcon – Here’s Why - Stocktwits
STAAR confirms no competing bids emerged during Alcon merger window By Investing.com - Investing.com Nigeria
STAAR draws no rival bids as Yunqi joins Broadwood against Alcon deal - Investing.com Canada
Yunqi Capital opposes STAAR Surgical’s merger with Alcon By Investing.com - Investing.com South Africa
STAAR confirms no competing bids emerged during Alcon merger window - Investing.com India
Staar has no competing bids, another shareholder rejects Alcon buy - BioWorld MedTech
Yunqi Capital Announces its opposition to the STAAR Surgical? s proposed sale to Alcon - MarketScreener
Merger Agreement Advances as Alcon (ALC) Clears 'Window Shop' Pe - GuruFocus
Fort Worth weighs incentives for Alcon; Dallas mulls permit for outdoor concerts in Design District - The Business Journals
Yunqi Capital Opposes Staar Surgical (STAA) Sale to Alcon - GuruFocus
Yunqi Capital Rejects Alcon's Acquisition Proposal of STAAR Surg - GuruFocus
Yunqi Capital opposes STAAR Surgical’s merger with Alcon - Investing.com
Staar Surgical urges shareholders to back Alcon merger as “window shop” period ends (STAA:NASDAQ) - Seeking Alpha
Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon - Bluefield Daily Telegraph
Refractive Surgery Market Booming Rapidly by 2032: Alcon Inc., Johnson & Johnson Vision, Bausch + Lomb - openPR.com
Trade Recap: Does Alcon Inc stock benefit from AI growthPortfolio Value Summary & Verified Short-Term Plans - خودرو بانک
VIX Spike: Is Alcon Incs growth already priced inDip Buying & Free Community Consensus Stock Picks - khodrobank.com
Pullback Watch: What is the next catalyst for PTMNTrade Risk Assessment & Weekly High Return Forecasts - khodrobank.com
Bond Watch: Will Alcon Inc benefit from rate cutsMarket Activity Summary & Reliable Price Breakout Signals - khodrobank.com
Fuchs endothelial corneal dystrophy Market Analysis: Epidemiology Insights, Therapies, Companies, by DelveInsight | Kowa Pharmaceuticals, Trefoil Therapeutics, Alcon - Barchart.com
Alcon's UNITY VCS Shows Superior Efficiency in Studies, Stock Up - Nasdaq
Aug Retail: Should I hold or sell Tectonic Therapeutic Inc. nowIPO Watch & AI Enhanced Market Trend Forecasts - خودرو بانک
Alcon to Buy Staar for $1.5 Billion in Vision Surgery Expansion - MSN
Alcon AG stock hits 52-week low at $77.34 amid challenging year By Investing.com - Investing.com South Africa
Alcon AG stock hits 52-week low at $77.34 amid challenging year - Investing.com Australia
Growth Value: What is Alcon Inc.’s book value per share2025 Year in Review & High Accuracy Investment Signals - خودرو بانک
Gains Report: What is Bakkt Holdings Inc Equity Warrants 5 year growth outlook2025 Top Gainers & Free High Accuracy Swing Entry Alerts - خودرو بانک
Staar Surgical issues letter to stockholders regarding Alcon merger - Yahoo Finance
Trading Action: Is Alcon Inc forming a breakout patternJuly 2025 Volume & Fast Moving Stock Watchlists - خودرو بانک
Alcon upgraded to neutral by Redburn, operational execution cited - MSN
Tools to monitor Alcon Inc. recovery probabilityInsider Selling & Daily Market Momentum Tracking - newser.com
STAAR Surgical Announces Merger with Alcon - TipRanks
RBC Capital Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $100.73 - 富途牛牛
Fuchs Endothelial Corneal Dystrophy Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | ProQR Therapeutics, Kowa Pharmaceuticals, Trefoil Therapeutics, Alcon Inc., Emmecell - Barchart.com
51% Premium: Medical Device Leader Alcon to Acquire STAAR Surgical in Premium Cash Deal Worth $28 Per Share - Stock Titan
Alcon (ALC) Boosts Surgical Efficiency with Unity Vitreoretinal Cataract System - GuruFocus
Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency* for Cataract and Vitreoretinal Surgery with UNITY VCS - Yahoo Finance
Risk Check: Whats the MACD signal for Alcon IncShare Buyback & Consistent Income Trade Ideas - خودرو بانک
Alcon (ALC) to Acquire Staar Surgical in $28 Per Share Cash Deal - GuruFocus
Alcon (ALC) Receives a Buy from RBC Capital - The Globe and Mail
Alcon Inc (ALC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.51%
자본화:
|
볼륨(24시간):